Calibrator Set Atellica® IM SARS-CoV-2 Antigen 4 X 1 mL For Calibrating the Atellica IM CoV2Ag Assay using an Atellica Immunoassay Analyzers
11208048 | USAMP#68691031
container type
form
volume
Secure Checkout
Verified Supply Chain
Priority Fulfillment
Locked
Base Price
$471.27
PK
🎯 Unlock Your Custom Tiered Price
15-35% bulk discounts
100+
units
10% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
250+
units
20% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
500+
units
30% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
Unlock Bulk Pricing
See pricing for all volume tiers
Instant access to volume pricing. Register free to compare all tiers and calculate your exact savings.
5,000+ verified buyers
Average savings:$23,400/year
15-35% OFF
for healthcare facilities on bulk orders
24/7 Live Chat!
Instant support anytime
Product Spotlight
- The Atellica® IM SARS-CoV-2 Antigen (CoV2Ag) assay is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate or high complexity tests
- The Atellica IM SARS-CoV-2 Antigen (CoV2Ag) assay does not differentiate between SARS-CoV and SARS-CoV-2
- Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status
- Positive results do not rule out bacterial infection or co-infection with other viruses
- Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
- Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management may be performed; negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
- Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19
- Kit contains: 2 x 1.0 mL low calibrator, 2 x 1.0 mL high calibrator and calibrator lot-specific value sheet
- For Use Under Emergency Use Authorization Only
- For in vitro diagnostic use
- For Prescription Use
- For Professional Use
